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Sex-speciﬁcityVulnerability of the fetus upon maternal obesity can potentially occur during all developmental phases. We
aimed at elaborating longer-term health outcomes of fetal overnutrition during the earliest stages of develop-
ment.WeutilizedNavalMedical Research Institute (NMRI)mice to induce pre-conceptional and gestational obe-
sity and followed offspring outcomes in the absence of any postnatal obesogenic inﬂuences. Male adult offspring
developed overweight, insulin resistance, hyperleptinemia, hyperuricemia and hepatic steatosis; all these
features were not observed in females. Instead, they showed impaired fasting glucose and a reduced fat mass
and adipocyte size. Inﬂuences of the interaction of maternal diet ∗ sex concerned offspring genes involved in
fatty liver disease, lipid droplet size regulation and fat mass expansion. These data suggest that a peri-
conceptional obesogenic exposure is sufﬁcient to shape offspring gene expression patterns and health outcomes
in a sex- and organ-speciﬁc manner, indicating varying developmental vulnerabilities between sexes towards
metabolic disease in response to maternal overnutrition.
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Table 1
Diet compositions.
High-fat, high-calorie
diet (HFD)
Control
diet (CD)
Maintenance
diet (MD)
Crude nutrients (g/100g)a
Crude protein 24.1 24.1 19.3
Crude fat 34.0 5.1 3.4
Crude ﬁber 6.0 6.4 5.0
Crude ash 6.1 6.2 6.5
N free extracts 27.0 54.7 55.3
Myristic acid (C14:0) 1.03 0.06 0.01
Palmitic acid (C16:0) 8.06 0.70 0.47
Stearic acid (C18:0) 5.61 0.37 0.08
Oleic acid (C18:1) 12.13 1.44 0.62
Starch 2.2 26.0 37.5
Sugar / dextrines 22.4 26.1 4.7
Energy (%) derived from
Protein 19.0 27.0 33.0
Carbohydrates 21.0 60.0 58.0
Fat 60.0 13.0 9.0
Total energy (MJ/kg) 21.4 15.1 13.0
N, nitrogen.
a Single diet components are denoted in g per 100 g diet.
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Human epidemiological studies show that the offspring's risk of de-
veloping obesity in later life is strongly associatedwithmaternal obesity
[1]. Among the various perinatal risk factors for the development
of childhood obesity, pre-conceptional maternal obesity confers the
strongest risk [2,3]. This ﬁnding is supported by evidence of a decreased
offspring obesity risk subsequent to maternal weight-loss surgery [4].
It seems likely that more than one critical time window during
development plays a role in programming offspring disease risks [5].
To address this hypothesis, animal studies are needed in order to sepa-
rate the wide range of confounding exposures and factors during the
developmental phases that can inﬂuence offspring health outcome.
Various animal models have already been used to address the
transgenerational impact of diet-induced obesity by fetal exposures
throughout pregnancy and also the lactation period [5], which repre-
sents a critical time window for programming in rodents [6,7]. In
humans, this period of developmental plasticitymost likely corresponds
to the third trimester of pregnancy and may expand into postnatal life
[8]. However, only very few rodent studies have speciﬁcally investigat-
ed the transgenerational effects ofmaternal pre-gravid obesity and dur-
ing the gestational period [9,10], although an impact on oocyte and
early embryo development has been suggested [11,12].
Whereas rodent offspring outcomes have so far mostly been deter-
mined in males [13], few studies have analyzed the impact of an
adipogenic exposure during thepregnancy and lactation period by com-
paring both sexes separately, as reported from rat [14–16] and mouse
models [17–19]. In humans, associations between parental body mass
index and children's weight and body fat are reported to be sex-
dependent, an observation not being explained as yet [20,21]. Develop-
mental components to sex-speciﬁc differences in human disease risk
have also been reported for several common disorders [22], such as in
diabetes [23].
Most rodent studies utilized inbred mouse strains such as C57BL/6J
that upon obesogenic feeding develop pronounced obesity already
being complicated by hyperinsulinemia, hyperleptinemia, and dyslipid-
emia [17,24,25]. However, in the human situation, a substantial propor-
tion of fertile obese women still have largely compensated metabolic
homeostasis [26,27].We hypothesized that exposure during the earliest
developmental stages of life even to milder forms of maternal obesity
is already sufﬁcient to induce programming of long-term health risks
in offspring of each sex. Thus, we aimed at utilizing a mouse model
showing less pronouncedmaternal adiposity during early developmen-
tal stages. For this purpose, we took advantage of the outbred Naval
Medical Research Institute (NMRI) mouse stock that is less vulnerable
to the consequences of high-fat feeding than the C57BL/6J strain [28].
In the offspring of NMRI dams, we assessed long-term phenotypic
outcomes, metabolic features, and underlying gene expression proﬁles
in each sex separately and at different life times. Offspring were trans-
ferred to foster dams to speciﬁcally preclude programming inﬂuences
during lactation and were subsequently grown up in the absence of
any additional postnatal high-fat diet exposure. Nevertheless, in later
life of offspring we demonstrated signs of metabolic disease associated
with differential gene expression patterns that strikingly differ between
sexes and that are evoked by the obesogenic environment of dams in
the pre-conceptional period and early phase of development.
2. Materials and methods
2.1. Experimental design
Male and female NMRI mice (RjHan:NMRI; originally Swiss mice
transferred to the US Naval Medical Research Institute, then to the
Central Institute for Laboratory Animal Breeding, Hannover, Germany
in 1958) were purchased from Janvier (Le Genest St Isle, France). This
outbred stock is characterized by an albino appearance, a rapid growthrate, a high success of reproduction, and large litter sizes [29].Micewere
maintained under speciﬁc pathogen-free conditions in the closed barrier
facility of the Gene Center Munich at 23 °C, 40% humidity and with a
12 h light/dark cycle (lights on at 7 AM). All animals had free access to
their speciﬁc rodent diet andwater ad libitum. All experiments were ap-
proved by the Committee onAnimalHealth and Care of the local govern-
mental body of the state of Bavaria and performed in strict compliance
with the European Economic Commission (EEC) recommendations for
the care and use of laboratory animals (European Communities Council
Directive of 24th November 1986 [86/609/EEC]).
28 female NMRI mice at 3 weeks of age were randomly distributed
into a total of 3 groups. Two groups (7 mice each) received the D12492
high-fat, high-calorie diet (HFD) (E15741-34; Ssniff, Soest, Germany)
or the control diet to D12492 (CD) (Ssniff; Table 1, Supplemental Fig.
A.1). We used the term “HFD” being aware that apart from a high-
saturated fat content, the carbohydrate composition was characterized
by a ratio of 10:1 of sugar to starch. The third group (foster mothers,
14 mice) received a standard maintenance rodent diet (MD) (V1536,
Ssniff; Table 1) after arrival to the animal facility (Supplemental
Fig. A.1). Bodyweightwasmonitored every three days and body compo-
sition was measured weekly. At the age of 12 weeks, mice were mated
and screened for vaginal plugs every morning and evening. Females of
the experimental groups remained on their speciﬁc diets and those of
the foster group were on CD during pregnancy and lactation to ensure
that any postnatal dietary exposure of offspring was only to CD.
The term “peri-conceptional” was used to refer to maternal obesity
prior to conception and during the earliest developmental phases
including early gestational periods equivalent to the ﬁrst and second
trimesters in humans. Pregnant females were weighed and their body
composition was analyzed every three days. All animals were allowed
to give birth naturally. Within 12 h after birth, each litter of the two
experimental groups (HFD, CD) was adjusted to a size of 8 animals by
culling surplus pups, and directly transferred to one of the dams of
the foster group, which gave birth the same day andwhose pupswere re-
moved (Supplemental Fig. A.1). All litters in each maternal group were
greater than 8 pups andnone of the damswere excluded due to large var-
iations in litter size. To avoid any selection inﬂuence of the experimenter,
offspring were randomly chosen regardless of sex, size or other features.
Offspring were weighed every three days. At day 21, all offspring
were weaned onto CD. Thereafter, body composition of offspring was
monitored weekly and from week eight onwards every two weeks up
to 5 months of life, when mice became too large for analysis of body
composition. At age 9 months, offspring were sacriﬁced. In a separate
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months, respectively. After fasting for 12 h, animals were bled from
the retro-orbital plexus under short-term (b30 s) ether anesthesia
and killed by cervical dislocation. Ether anesthesia can induce systemic
metabolic and hormonal alterations in rodents and humans [30]
through enhanced lipid peroxidation following deep anesthesia of at least
several minutes [31,32]. Therefore, we applied only short-time ether expo-
sition for taking blood samples, alongwith dietary supplementation of high
antioxidant concentrations (150 mg vitamin E per kg diet) [33].
Organs were dissected, blotted dry, and weighed to the nearest mg.
Visceral adipose tissue was removed from the entire visceral cavity and
comprised perirenal, omental, and periovarian fat depots. Tissue sam-
ples were immediately processed and either frozen at −80 °C, ﬁxed
in 4% paraformaldehyde (PFA) (pH 7.4), or ﬁxed in RNAlater (Qiagen,
Hilden, Germany) and frozen at−20 °C.
2.2. Body composition analysis and metabolic phenotyping
Body composition (% fat and lean mass) was assessed using a
magnetic resonance imaging (MRI) analyzer (Minispec LF50; Bruker,
Karlsruhe, Germany) without anesthesia.
2.2.1. Offspring calorimetric analysis, movement activity, body tempera-
ture, and food intake
Offspring prenatally exposed to maternal HFD were named “mat-
HFD” and offspring of lean mothers “mat-CD”. Metabolic phenotyping
of mat-CD and mat-HFD offspring was performed in the Energy
Metabolism Screen of the German Mouse Clinic, Helmholtz Zentrum
München, at an age of 5 months (n = 7 per maternal diet and sex)
[34]. Mice were caged in groups of 3 to 4 animals in individually venti-
lated Makrolon type II cages. Room temperature was set to 23 °C; the
light/dark cycle in the room was 12:12 h (lights on at 06:30 Central
European Time [CET], lights off at 18:30 CET). Mice were weighed every
week. About three weeks after entering the Mouse Clinic, energy expen-
diture was monitored by indirect calorimetry (SM-MARS-8A; Sable Sys-
tems, Las Vegas, USA). High precision CO2 and O2 sensors measured the
difference in CO2 and O2 concentrations in air volumes ﬂowing through
a reference control cage or the animal cages. O2 consumption (VO2,
ml h−1 animal−1) and CO2 production (VCO2, ml h−1 animal−1) were
calculated from gas concentrations and the air ﬂow through the cage
measured in parallel. Respiratory exchange ratio (RER) as an indicator
for metabolic fuel utilization was calculated as the ratio VCO2/VO2.
Heat production (HP)was calculated fromVO2 andRERusing the formu-
la: HP [mW] = (4.44 + 1.43 × RER) × VO2 [ml h−1]. Each mouse was
individually placed in the chamber for a period of about 21 h (from
14:00 CET to 11:00 CET next day) with free access to food and water.
Air from each individual mouse channel was sub-sampled every 10 min
and used for gas analysis.
Locomotor activity was monitored during this time period, as cages
were set up on motion sensitive detector plates that registered ﬁne
movements induced by the mouse. These data were used as quantita-
tive estimate for ambulatory behavior. Metabolic chambers were set
up in a ventilated cabinet continuously supplied with an overﬂow of
fresh air from outside. In addition, body mass was analyzed before and
after the gas exchange measurements. Before returning the mice to
their home cage, rectal body temperature was also determined. Food
intake during the trial was monitored by weighing and re-weighing
the feeder before and after indirect calorimetry.
2.2.2. Determination of food assimilation coefﬁcient
In a separate experiment, three groups of female NMRI mice were
fed either MD (n = 6), CD (n = 7) or HFD (n = 7) starting at the age
of three weeks. At the age of 12 weeks, mice were separated in single
regular home cages with grid panels on the ground to allow the collec-
tion of feces and accurate monitoring of food intake. Mice were kept on
their respective diets throughout the experiment. Body mass, foodconsumption, daily feces production, and the energy content of the
feces were measured, whereas energy intake, assimilated energy,
and the food assimilation coefﬁcient were calculated from raw data.
Samples of experimental diets and feces (~1 g) were dried at 60 °C
for two days, homogenized, and squeezed to a pill for determination
of energy content in a bomb calorimeter (IKA Calorimeter C7000; Ika
GmbH & Co KG, Staufen, Germany). Energy intake is determined as
the product of food consumed and the caloric value of the food. To ob-
tain assimilated energy, the energy content of feces was subtracted
from energy intake. The food assimilation coefﬁcient was calculated
as the percentage of total energy intake that was assimilated [food as-
similation coefﬁcient = (assimilated energy × 100) / energy intake].
2.3. Glucose tolerance test
To perform a glucose tolerance test (GTT), 1.5 g glucose per kg body
weight was administered intraperitoneally. Blood samples were taken
from the punctured tail vein at 0, 20, 40, 60, 80, 100, and 120 min
after glucose injection and were immediately measured using a
glucometer (Abbott MediSense, Wiesbaden, Germany) [35]. In off-
spring, a GTT was performed at age 5 months after fasting for 12 h
(n = 7 per maternal diet and sex). For a GTT during gestation, a sepa-
rate cohort of dams was used to avoid possible in utero inﬂuences of
the GTT on the investigated offspring. Two groups (7 mice each) were
housed individually, fed either HFD or CD, monitored for weight and
body composition, and mated as described above. Pregnant females
were fasted 6 h at 16.5 days post coitum (dpc) prior to the GTT. One
day later, cesarean sections were performed and dams were sacriﬁced.
Placenta and fetal weights were measured.
2.4. Computed tomography method for determining liver fat content
A computed tomography (CT) X-ray scanner (La Theta; Aloka Ltd.,
Tokyo, Japan) was used for the non-invasive determination of liver fat
content of male and female offspring at age 5 months. CT values of de-
ﬁned tissues decrease with increasing fat content (typically −300 to
−100 Hounsﬁeld units for adipose tissue). We made use of this rela-
tion and estimated the degree of liver steatosis by measuring X-ray
attenuation in CT images of the liver [36]. The X-ray source was pre-
set at a current of 1 mA and a voltage of 50 kV. An animal holder
with an outer diameter of 48 mm and inner diameter of 41 mm was
applied, resulting in pixel resolutions of 100 μm on 480 × 480 pixel
images. Mice were sedated by continuous 2–2.5% isoﬂurane inhala-
tion. Based on a sagittal pre-scan, ﬁxed anatomical landmarks were
used to deﬁne a region from the proximal end of the eleventh thoracic
vertebra to the distal end of the third lumbar vertebra. The scan speed
was set to 4.5 s/image; the slice pitch was 1 mm. Recorded scans
were analyzed using the software La Theta 2.10. A polygonal region
of interest (ROI) in the ventral part of the liver was deﬁned in three
consecutive slices. CT values of these ROIs were averaged to determine
liver attenuation as an estimate for fat content.
2.5. Histological analyses and determination of adipocyte size
Liver and adipose tissue specimenswere ﬁxed in 40 g/l buffered PFA
(Serva Electrophoresis, Heidelberg, Germany) for 24 h, embedded in
parafﬁn (SAV LP, Flintsbach am Inn, Germany), sectioned at 3 μm (HM
315; Microm, Walldorf, Germany), and stained with hematoxylin–
eosin (H&E) for routine histopathological examination. For liver fat
staining, 10 μm cryosections (Reichert-Jung 2800 Frigocut; Cambridge
Instruments, Nussloch, Germany) were prepared from frozen PFA-
ﬁxed liver tissue, mounted on glass slides, incubated with Fat Red 7B
(Sigma-Aldrich Chemie, Taufkirchen, Germany), washed with distilled
water, and counterstained with hemalum (AppliChem, Darmstadt,
Germany). All specimenswere interpreted by a pathologist in a blinded
fashion. In addition, the severity of hepatic steatosis in dams was
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applying a semiquantitative grading system [37]. Liver sections were
evaluated in a blinded manner twice over the course of 2 days by the
same investigator and were additionally assessed by an independent
pathologist.
The histological H&E stained sections of visceral and subcutaneous
adipose tissue of offspring were captured at 20× magniﬁcation on an
Olympus Fluoview FV1000 microscope equipped with Cell B image
capturing software (Olympus Europe, Hamburg, Germany). The images
were converted into binary format using ImageJ (http://rsb.info.nih.
gov/ij) and GIMP (www.gimp.org) according to [38]. Binary images
were then manually compared to the original images to ensure an ac-
curate conversion. If necessary, minor adjustments were made by sep-
arating overlapping areas. Cross-sectional proﬁles of 50 adipocytes per
histological sample of each animal were analyzed in a blinded fashion
to obtain areas in μm2.
2.6. Analyses of serum biochemistry, adipocytokines, endocrine status, and
reactive oxygen species
Prior to sacriﬁce, mice were starved for 12 h, blood was taken, and
serum samples were stored at−80 °C. Analyses of clinical chemical pa-
rameters were carried out as described previously [39]. Brieﬂy, samples
were thawed and analyzed the same day using an AU400 autoanalyzer
(Olympus, Hamburg, Germany) and adapted reagent kits fromOlympus
(now available from Beckman Coulter, Krefeld, Germany) or Wako
Chemicals GmbH (Neuss, Germany) for the analysis of non-esteriﬁed
fatty acids (NEFA). Serum leptin concentrations were measured
using the Quantikine Mouse Leptin Immunoassay (R&D Systems,
Wiesbaden-Nordenstadt, Germany) according to the manufacturer's
instructions. Serum samples of the pregnant females were subjected
to acid/urea activation and subsequently neutralized prior to
performing the ELISA to avoid cross-reactivity with a soluble form of
the leptin receptor which is secreted by the mouse placenta from
midgestation onwards [40]. Adiponectin secretion was determined
by using the high-molecular-weight (HMW) and total adiponectin
(mouse) ELISA kit from ALPCO (Salem, USA). Each sample was assayed
in duplicate 1:10 diluted for total adiponectin and 1:5 diluted for HMW
adiponectin.
For themeasurement of serum insulin concentrations, anUltrasensi-
tive Mouse Insulin ELISA (Mercodia, Uppsala, Sweden) was used ac-
cording to the manufacturer's protocol. Thiobarbituric acid-reactive
substances (TBARS) were measured using a TBARS Assay Kit (Cayman,
Tallin, Estonia) to assess the level of lipid peroxidation in undiluted
serum samples. Serum H2O2 was measured using the Amplex Red
Hydrogen Peroxide/Peroxidase Assay Kit (Invitrogen, Darmstadt,
Germany) according to the manufacturer's instructions.
2.7. Gene expression analyses
Total RNA was extracted from RNAlater-conserved frozen liver and
visceral adipose tissue of offspring using the Nucleospin RNA II kit
(Macherey-Nagel, Düren, Germany), and 1 μg of RNA was reverse
transcribed into cDNA using the QuantiTect Reverse Transcription
Kit (Qiagen), both according to the manufacturer's instructions.
Quantitative real-time RT-PCR was carried out on the StepOnePlus Sys-
tem (Applied Biosystems, Foster City, USA) using Power SYBR Green
(Applied Biosystems). 40 cycles were run for each reaction with 15 s
at 95 °C for denaturation, 15 s at 55 °C for annealing and 1 min at
60 °C for extension. All measurements were done in triplicates. mRNA
expression levels were calculated relative to the mean of the house-
keeping genes peptidylprolyl isomerase A (Ppia) (liver and visceral fat,
age 9 months), ubiquitin-conjugating enzyme E2D 2 (Ube2d2) (visceral
fat, age 5 months), or beta-actin (Actb) (liver, age 5 months) used as
reference.2.8. Statistical analyses
Data for body weight and body composition as well as glucose tol-
erance were statistically analyzed using PROC MIXED (linear mixed
models; SAS release 8.2, SAS Institute, Cary, NC, USA) taking into ac-
count the ﬁxed effects of diet (CD, HFD), age/time, the interaction of
diet ∗ age/time, and the random effect of animal [41]. For the analysis
of offspring data (body weight, body composition), mother within diet
[mother(diet)] was included in the model as an additional ﬁxed effect
to account for the fact that offspring of the same litter developed in the
same maternal environment.
For subgroup selections, offspring were ranked according to body
fat (%) and selected across the range. Square root transformed gene
expression data and serum parameter concentrations were analyzed
using PROC GLM (general linear models; SAS release 8.2) taking into
account the ﬁxed effects of diet, sex, and the interaction of diet ∗ sex.
Signiﬁcance of individual differences was tested by Tukey's post hoc
test. Linear regression models were applied for analysis of metabolic
phenotyping data [42]. Two-way analysis of variance (ANOVA) of
square root transformed data followed by Holm–Sidak post hoc
test was used to compare differences in liver CT Hounsﬁeld units.
Kruskal–Wallis test followed by Dunn's test was used to detect dif-
ferences in adipocyte size.
The remainder of the statisticswas performed in GraphPad Prism 4.0
(GraphPad Software, San Diego, USA) using the nonparametric Mann–
Whitney U-test (two-tailed) to assess differences in organ weights,
fetal and placenta weights, birth weights, litter size, area under the glu-
cose curve of the GTT, liver steatosis score, food and energy intake,
serum parameters, and transcript levels between two groups of animals
each. Data are presented as mean ± standard error of the mean
(s.e.m.); p b 0.05 was considered signiﬁcant.
3. Results
3.1. Composition and digestibility of maternal experimental diets
To ensure comparable digestibility of CD andHFD, which is enriched
in long-chain saturated fatty acids, content and source of protein
and ﬁber were kept equal (Table 1). A similarly high digestibility
of both diets was conﬁrmed in a separate experiment by analyzing
food assimilation efﬁciencies following HFD or CD intake in NMRI
mice from 3 to 12 weeks of age (mean ± s.e.m.; HFD: 93.20 ± 0.39%,
CD: 91.53 ± 0.22%). Mineral, trace element, and vitamin content of
the diets were also matched. Both diets differed in total fat content,
with 60% of energy derived from fat in the HFD compared to 13% in
the CD, and in carbohydrate composition, with a ratio of 10:1 of sugar
to starch in the HFD compared to a ratio of 1:1 in the CD. The HFD
exceeded the CD in total energy content. Although food intake
was lower in the HFD-fed dams (mean ± s.e.m.; HFD: 3.1 ± 0.1, CD:
3.5 ± 0.1 g/mouse per day, p = 0.014) most likely as a regulatory
response [43], the resulting total energy intake was signiﬁcantly
higher in the HFD group (mean ± s.e.m.; HFD: 67.3 ± 2.1, CD:
53.3 ± 1.3 kJ/mouse per day, p b 0.0001). Consequently, protein in-
take (mean ± s.e.m.; HFD: 0.8 ± 0.02, CD: 0.9 ± 0.02 g/mouse per
day, p = 0.014) and energy intake resulting from protein (mean ±
s.e.m.; HFD: 12.8 ± 0.4, CD: 14.4 ± 0.4 kJ/mouse per day, p = 0.014)
were slightly lower in the HFD-fed dams.
3.2. Inﬂuence of obesogenic nutrition before and during pregnancy on
NMRI dams
From the age of 8 to 9 weeks onwards, pre-conceptional weight gain
and body fat mass of the HFD-fed NMRI dams were signiﬁcantly
increased compared with CD-fed animals (Fig. 1A, B). Reproductive
performance appeared to be only slightly inﬂuenced by the diet: the
fertility rate was 100% (7/7) for each dietary group of mothers, which
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Fig. 1.Maternal obesogenic environment before andduringpregnancy. (A) Pre-pregnancy bodyweight and (B) body fat of the control diet (CD) group andhigh-fat, high-calorie diet (HFD)
group of dams (n = 7/group). ANOVA revealed signiﬁcant effects of age (p b 0.0001) and the interaction diet ∗ age (p b 0.0001) on bodyweight and signiﬁcant effects of diet (p b 0.05),
age (p b 0.0001), and diet ∗ age (p b 0.001) on body fat. Differences between groups were analyzed by Tukey's post hoc test. (C) Intraperitoneal glucose tolerance test performed on ges-
tational day 16.5 (n = 5/group). ANOVA revealed signiﬁcant effects of the diet (p b 0.01), time (p b 0.0001), and diet ∗ time interaction (p b 0.001). Differences between groups were
analyzed by Tukey's post hoc test. AUC = area under the curve of the HFD group versus CD group. (D) Maternal liver histology of animals of the HFD and CD group. Parafﬁn sections,
H&E stain (left panel); cryosections, fat-red stain (right panel). Scale bars represent 100 μm. (E) Placentaweights and (F) bodyweight of fetuses fromCD- andHFD-fedmice on gestational
day 17.5 (E17.5) (n = 81 CD/72 HFD). Mean ± s.e.m., *p b 0.05, **p b 0.01, ***p b 0.001.
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17.5 dpc, it was 86% (6/7) for the HFD-fed dams versus 100% (7/7) for
the CD-fed dams. At the end of gestation, animals fed with HFD showed
a moderately impaired glucose tolerance, whereas fasting glucose con-
centrations and values of the homeostatic model assessment of insulin
resistance (HOMA-IR) were unchanged compared to controls (Fig. 1C,
Supplemental Table A.1). NEFA levels were increased in the HFD group
(mean ± s.e.m.; HFD: 0.95 ± 0.11 mmol/l, CD: 0.48 ± 0.06 mmol/l,
p b 0.01); however, there were no other signs of dyslipidemia. Urea
values were signiﬁcantly lower in the HFD-fed group (mean ± s.e.m.;
HFD: 5.39 ± 0.47 mmol/l, CD: 7.74 ± 0.32 mmol/l, p b 0.01) possibly
pointing to a lower protein catabolism than in the CD-fed groups.
Liver histology suggested a tendency, although not statistically sig-
niﬁcant, towards a higher microvesicular fat deposition in HFD-fed
dams compared to the control group, as evidenced by steatosis grading
(mean ± s.e.m.; HFD: 2.1 ± 0.2, CD: 1.5 ± 0.1, p = 0.057) (Fig. 1D).
However, there was no histological and clinical chemical evidence
of liver injury and inﬂammation (Supplemental Table A.1). SerumH2O2 was signiﬁcantly elevated in HFD-fed dams (mean ± s.e.m.;
HFD: 114.81 ± 17.02 nmol/ml, CD: 29.33 ± 6.46 nmol/ml, p b 0.01);
however, there were no signiﬁcant differences in the levels of
serum adipocytokines (leptin, adiponectin) or the inﬂammatory
marker C-reactive protein between both groups.
While the litter size was not inﬂuenced by thematernal diet (cohort
of 9-month-old offspring:mean ± s.e.m.; HFD: 14.7 ± 0.7, n = 103; CD:
13.6 ± 0.8, n = 95, p = 0.26; cohort of dams sacriﬁced at 17.5 dpc:
HFD: 11.7 ± 1.0, n = 72; CD: 12.2 ± 1.3, n = 81, p = 0.73), both
mean placenta and corresponding fetal weights at 17.5 dpc were signiﬁ-
cantly increased in the HFD group (Fig. 1E, F).
3.3. Sex-speciﬁc effects on body composition and metabolic outcome in
adult offspring
Only a few days after birth, the initial differences in birth weight be-
tween mat-HFD and mat-CD offspring groups of both sexes disap-
peared, while all offspring were suckling on lean dams (Fig. 2A, B,
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Fig. 2.Male and female offspring body composition. (A) Body weight in early postnatal life, (C) body weight until adulthood, and (E) relative body fat of male offspring following peri-
conceptional exposure to maternal control diet (mat-CD) or maternal high-fat, high-calorie diet (mat-HFD) (n = 22 mat-CD/30 mat-HFD). ANOVA revealed a signiﬁcant effect of diet
for (C) (p b 0.05) and (E) (p b 0.01) and a signiﬁcant effect of age (p b 0.0001) for (A, C, E). A signiﬁcant effect of the interaction diet ∗ age was detected for (A) (p b 0.01) and (C, E)
(p b 0.0001) and effect of mother for (A, C) (p b 0.0001) and (E) (p b 0.01). Signiﬁcance of individual differences was tested by Tukey's post hoc test. (B) Body weight in early post-
natal life, (D) body weight until adulthood, and (F) relative body fat of female offspring of the mat-CD group and mat-HFD group (n = 27 mat-CD/18 mat-HFD). ANOVA revealed a
signiﬁcant difference in the effect of age and mother (p b 0.001) for (B, D, F) and in the effect of diet (p b 0.01) for (F) accompanied by a trend towards an effect of diet ∗ age inter-
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analysis of body composition by the MRI analyzer (Minispec LF50; Bruker). The insets (A, B) show signiﬁcant differences in birth weight between mat-CD and mat-HFD male offspring
(p = 0.036) and female offspring (p = 0.006), which vanished while they were foster-nursed by lean dams. Mean ± s.e.m., *p b 0.05, **p b 0.01, ***p b 0.001.
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time (Supplemental Fig. A.1), male mat-HFD offspring developed a sig-
niﬁcant increase in body weight and fat mass compared to mat-CD
males from 10 and 6 weeks of age onwards, respectively (Fig. 2C, E).Unexpectedly, mat-HFD female offspring showed an entirely different
response and, although body weight was unaffected, they presented
with a signiﬁcantly lower body fat content than controls, from age
16 weeks onwards (Fig. 2D, F). These alterations in mat-HFD offspring
Table 2
Metabolic phenotyping in offspring. Food intake, movement activity, indirect calorimetry,
and rectal body temperature of mat-CD and mat-HFD offspring at the age of 5 months.
Male Female
Parameter Mat-CD
(n = 7)
Mat-HFD
(n = 7)
Mat-CD
(n = 7)
Mat-HFD
(n = 7)
Food intake
(g/mouse per day)
6.2 ± 0.5 6.3 ± 0.3 4.6 ± 0.5 5.2 ± 0.3
Activity
(counts × 100)
7.37 ± 3.0 8.79 ± 3.8 5.88 ± 3.3 8.41 ± 2.9
Respiratory quotient
(VCO2/VO2)
0.92 ± 0.01 0.90 ± 0.01 0.87 ± 0.01 0.87 ± 0.01
Metabolic rate (mW) 761.7 ± 25.9 850.0 ± 20.9 680.6 ± 18.6 756.2 ± 21.5
Body temperature (°C) 36.0 ± 0.2 35.9 ± 0.1 36.6 ± 0.2 36.5 ± 0.0
Mat-CD, exposure to maternal control diet; mat-HFD, exposure to maternal high-fat,
high-calorie diet; VCO2, carbon dioxide production; VO2, oxygen consumption. Data are
presented as mean ± s.e.m.
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temperature, or energy expenditure (Table 2).
Differences in body weight and body composition were maintained
and conﬁrmed at the time of dissection at 5 and 9 months of life, respec-
tively (Table 3). Dissection data at 9 months conﬁrmed an increased
subcutaneous fat weight in the mat-HFD males and a signiﬁcant reduc-
tion in visceral fat weight in the mat-HFD females compared to their
mat-CD controls. However, liver and carcass weights relative to body
weight were signiﬁcantly increased in themat-HFD females, accounting
for similar body weights in the two female subgroups. Notably, as com-
pared to their controls, visceral fat was not yet detectable at early times
of 3 weeks of age in the mat-HFD females, and a signiﬁcant reduction
persisted throughout life. In addition, their subcutaneous fat weight
was also reduced at 5 months of age, a difference that vanished at the
later age of 9 months.Table 3
Absolute and relative organ weights of mat-CD and mat-HFD offspring at the ages of 3 weeks,
Parameter 3 weeks 5 month
Male mat-CD (n = 5) mat-HFD (n = 5) mat-CD (
Body weight (g) 11.06 ± 0.22 10.92 ± 0.51 37.61 ±
NRL (cm) - - 11.58 ±
Liver (g) 0.44 ± 0.02 0.45 ± 0.03 1.50 ±
Liver (% BW) 3.95 ± 0.11 4.10 ± 0.12 4.00 ±
Visceral fat (g) 0.00 ± 0.00a 0.00 ± 0.00a 0.18 ±
Visceral fat (% BW) 0.00 ± 0.00a 0.00 ± 0.00a 0.48 ±
Subcutaneous fat (g) 0.11 ± 0.01 0.10 ± 0.02 0.49 ±
Subcutaneous fat (% BW) 0.96 ± 0.08 0.89 ± 0.14 1.30 ±
Scrotal fat (g) 0.03 ± 0.001 0.03 ± 0.004 0.58 ±
Scrotal fat (% BW) 0.23 ± 0.01 0.23 ± 0.03 1.52 ±
M. quadrizeps (g) 0.06 ± 0.005 0.07 ± 0.003 0.27 ±
M. quadrizeps (% BW) 0.57 ± 0.04 0.64 ± 0.01 0.72 ±
Carcass (g) 4.42 ± 0.11 4.35 ± 0.2 15.82 ±
Carcass (% BW) 40.0 ± 1.06 39.9 ± 0.24 42.11 ±
Female mat-CD (n = 5) mat-HFD (n = 5) mat-CD (
Body weight (g) 10.86 ± 0.35 10.76 ± 0.31 33.42 ±
NRL (cm) - - 11.17 ±
Liver (g) 0.43 ± 0.03 0.46 ± 0.02 1.44 ±
Liver (% BW) 3.98 ± 0.18 4.31 ± 0.14 4.30 ±
Visceral fat (g) 0.015 ± 0.004 0.00 ± 0.00a 1.38 ±
Visceral fat (% BW) 0.14 ± 0.03 0.00 ± 0.00a 4.06 ±
Subcutaneous fat (g) 0.10 ± 0.01 0.08 ± 0.01 1.33 ±
Subcutaneous fat (% BW) 0.97 ± 0.13 0.77 ± 0.08 3.86 ±
M. quadrizeps (g) 0.07 ± 0.003 0.07 ± 0.003 0.20 ±
M. quadrizeps (% BW) 0.61 ± 0.02 0.65 ± 0.01 0.62 ±
Carcass (g) 4.42 ± 0.08 4.44 ± 0.20 13.31 ±
Carcass (% BW) 40.8 ± 0.64 41.2 ± 0.72 39.88 ±
BW, body weight; mat-CD, exposure to maternal control diet; mat-HFD, exposure to maternal
⁎ p b 0.05.
⁎⁎ p b 0.01.
⁎⁎⁎ p b 0.001.
a Visceral fat was not detectable.Fasting glucose levels and the results of a GTT performed at the
age of 5 months were not different between mat-HFD and mat-CD off-
spring, both inmales and females (data not shown). At 9 months of age,
prior to sacriﬁce, fasting glucose levels were still similar between mat-
HFD and mat-CD males but hyperinsulinemia and an increase
in HOMA-IR values were evident in the male mat-HFD subgroup
(Table 4). In contrast, the mat-HFD females displayed signiﬁcantly ele-
vated fasting glucose levels at the same age of 9 months, whereas
there was no hyperinsulinemia or increased HOMA-IR as in males.
Furthermore,malemat-HFD offspring showed hyperleptinemia andhy-
peruricemia but no signiﬁcant changes in serum lipid concentrations
(Table 4). Female offspring had none of those metabolic features. As in
the HFD-fed dams, but unlike in mat-HFD male offspring, urea levels
were decreased in the mat-HFD female offspring.
When sex-related differences of metabolic serum parameters were an-
alyzed by ANOVA,we found that fasting glucose, insulin, HOMA-IR, triglyc-
erides, cholesterol, LDL cholesterol, HDL cholesterol, HMW adiponectin,
uric acid, urea, and TBARS were signiﬁcantly inﬂuenced by sex (Table 4).
Among those, insulin, HOMA-IR and urea, as well as leptin were affected
by the interaction diet ∗ sex, pointing to an inﬂuence of the peri-
conceptional dietary exposure on the sex-related differences.
3.4. Sex-speciﬁc effects on liver metabolism in adult offspring
Fat content of the offspring livers was quantitated at the age of
5 months by measuring the X-ray attenuation in liver CT images.
Lower Hounsﬁeld units in the mat-HFD males indicated increased
liver fat accumulation compared to mat-HFD females (Fig. 3A). In con-
trast, there was no difference between sexes after in utero exposure to
a maternal CD environment.
In affected male mat-HFD livers, expression of genes involved in the
development of liver steatotic changeswas altered compared tomat-CD5 months, and 9 months.
s 9 months
n = 8) mat-HFD (n = 10) mat-CD (n = 21) mat-HFD (n = 29)
0.94 39.24 ± 0.70 52.79 ± 1.35 56.45 ± 1.08⁎
0.13 11.56 ± 0.08 11.99 ± 0.08 12.08 ± 0.07
0.08 1.63 ± 0.03 2.12 ± 0.10 2.36 ± 0.09
0.18 4.16 ± 0.06 4.03 ± 0.12 4.17 ± 0.12
0.04 0.27 ± 0.02 1.87 ± 0.14 1.98 ± 0.09
0.09 0.68 ± 0.05 3.48 ± 0.21 3.49 ± 0.13
0.06 0.53 ± 0.02 1.72 ± 0.13 2.99 ± 0.13⁎⁎⁎
0.14 1.34 ± 0.06 3.19 ± 0.19 5.26 ± 0.17⁎⁎⁎
0.10 0.72 ± 0.06 2.26 ± 0.14 2.06 ± 0.10
0.22 1.84 ± 0.15 4.27 ± 0.25 3.69 ± 0.20
0.009 0.26 ± 0.009 0.25 ± 0.01 0.26 ± 0.01
0.03 0.68 ± 0.02 0.47 ± 0.01 0.45 ± 0.01
0.30 15.70 ± 0.34 18.48 ± 0.33 20.06 ± 0.31⁎⁎
0.43 40.00 ± 0.39⁎⁎ 35.22 ± 0.58 35.66 ± 0.38
n = 9) mat-HFD (n = 10) mat-CD (n = 26) mat-HFD (n = 18)
1.00 30.26 ± 0.70⁎ 53.20 ± 1.70 51.56 ± 2.38
0.08 11.07 ± 0.11 11.87 ± 0.10 11.99 ± 0.10
0.05 1.31 ± 0.06 2.05 ± 0.10 2.21 ± 0.16
0.12 4.31 ± 0.14 3.83 ± 0.11 4.25 ± 0.18⁎
0.24 0.76 ± 0.09⁎ 9.14 ± 0.64 7.11 ± 0.60⁎
0.63 2.49 ± 0.28 16.59 ± 0.80 13.18 ± 0.69⁎⁎
0.26 0.71 ± 0.07⁎ 3.99 ± 0.24 3.51 ± 0.36
0.68 2.33 ± 0.21⁎ 7.35 ± 0.33 6.51 ± 0.50
0.007 0.20 ± 0.007 0.21 ± 0.01 0.22 ± 0.01
0.02 0.67 ± 0.02 0.40 ± 0.01 0.43 ± 0.02
0.38 12.48 ± 0.30 16.78 ± 0.29 17.65 ± 0.50
0.73 41.23 ± 0.32 32.04 ± 0.70 34.84 ± 0.89⁎
high-fat, high-calorie diet; NRL, nose–rump-length. Data are presented as mean ± s.e.m.
Table 4
Fasting serum analyses of mat-CD and mat-HFD offspring at the age of 9 months. The inﬂuence of the maternal diet, sex, and the interaction of maternal diet ∗ sex on serum parameters
was analyzed; p-values obtained using ANOVA are shown in the right part of the table. p b 0.05 was considered signiﬁcant (designated in boldface type).
Male Female
Parameter Mat-CD (n = 10) Mat-HFD (n = 13) Mat-CD (n = 12) Mat-HFD (n = 8) Maternal diet Sex Maternal diet ∗ sex
Glucose (mmol/l) 7.87 ± 0.75 8.78 ± 0.70 5.40 ± 0.33 6.96 ± 0.32** 0.0240 0.0006 0.4360
Insulin (pmol/l) 119.01 ± 16.99 276.62 ± 35.41** 144.92 ± 23.93 97.60 ± 18.12 0.1175 0.0075 0.0006
HOMA-IRa 7.20 ± 1.24 17.58 ± 2.35** 5.89 ± 1.07 4.90 ± 0.90 0.0203 0.0001 0.0026
NEFA (mmol/l) 0.99 ± 0.05 1.05 ± 0.07 0.98 ± 0.07 1.02 ± 0.09 0.5416 0.7714 0.9061
Triglycerides (mmol/l) 1.41 ± 0.15 1.20 ± 0.11 1.80 ± 0.21 1.74 ± 0.18 0.4756 0.0105 0.5912
Cholesterol (mmol/l) 4.21 ± 0.35 4.61 ± 0.27 2.59 ± 0.31 3.01 ± 0.13 0.1251 b0.0001 0.7259
LDL cholesterol (mmol/l) 0.43 ± 0.03 0.44 ± 0.03 0.32 ± 0.04 0.37 ± 0.01 0.2686 0.0144 0.4293
HDL cholesterol (mmol/l) 3.42 ± 0.26 3.79 ± 0.22 1.92 ± 0.22 2.32 ± 0.11 0.0637 b0.0001 0.6799
LDL/HDL ratio 0.13 ± 0.01 0.12 ± 0.005 0.17 ± 0.01 0.16 ± 0.01 0.2679 b0.0001 0.6166
Leptin (ng/ml) 14.27 ± 2.99 22.19 ± 1.56* 24.81 ± 4.13 19.47 ± 4.85 0.6014 0.5041 0.0394
HMW adiponectin (μg/ml) 10.26 ± 1.78 7.65 ± 0.84 20.87 ± 1.93 19.89 ± 2.03 0.2274 b0.0001 0.4703
HMW/total adiponectin ratio 0.76 ± 0.26 (n = 5) 0.32 ± 0.04 (n = 5) 0.48 ± 0.01 (n = 5) 0.51 ± 0.04 (n = 5) 0.1192 0.9160 0.0809
Uric acid (μmol/l) 95.91 ± 8.24 144.81 ± 18.09** 72.00 ± 4.63 88.21 ± 9.37 0.0074 0.0008 0.2360
Urea (mmol/l) 8.37 ± 0.26 8.47 ± 0.40 6.60 ± 0.37 5.22 ± 0.41* 0.0555 b0.0001 0.0393
Creatine kinase (U/l) 615.78 ± 80.16 628.31 ± 119.29 753.67 ± 71.98 719.50 ± 155.95 0.6186 0.3125 0.7633
Alanine transaminase (U/l) 58.80 ± 25.49 59.85 ± 14.04 35.17 ± 2.39 38.50 ± 5.12 0.6278 0.1416 0.8456
Aspartate transaminase (U/l) 148.80 ± 23.16 146.92 ± 21.15 139.50 ± 8.40 166.50 ± 19.71 0.5382 0.5896 0.4646
H2O2 (nmol/ml) 64.69 ± 4.18 59.99 ± 3.11 66.71 ± 3.07 63.52 ± 4.26 0.3066 0.4250 0.8620
TBARS (nmol MDA/ml) 3.23 ± 0.12 3.48 ± 0.23 2.54 ± 0.26 2.76 ± 0.29 0.7396 0.0160 0.4792
C-reactive protein (mg/l) 24.40 ± 6.50 27.23 ± 6.14 18.67 ± 5.44 13.50 ± 1.35 0.8175 0.0563 0.7770
HMWadiponectin, high-molecular-weight adiponectin; HOMA-IR, homeostaticmodel assessment of insulin resistance;mat-CD, exposure tomaternal control diet; mat-HFD, exposure to
maternal high-fat, high-calorie diet; MDA, malondialdehyde; NEFA, non-esteriﬁed fatty acids; TBARS, thiobarbituric acid-reactive substances. Data are presented as mean ± s.e.m.;
*p b 0.05, **p b 0.01. aHOMA-IR = [fasting insulin (μU/ml) × fasting glucose (mmol/l)]/22.5.
311M. Dahlhoff et al. / Biochimica et Biophysica Acta 1842 (2014) 304–317males at the ages of 5 and 9 months (Fig. 3B, Supplemental Fig. A.2A).
Alterations referred to lipogenic genes including fatty acid synthase
(Fasn) aswell as sterol regulatory element binding transcription factor 1
(Srebf1) and peroxisome proliferator activated receptor gamma (Pparg)
2, two nuclear receptors mediating nutrient effects and previouslyA
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Fig. 3. Liver steatotic alterations in adulthood ofmale but not female offspring exposed to a peri
offspring following peri-conceptional exposure tomaternal control diet (mat-CD; n = 6male/7
of 5 months. Statistically signiﬁcant differences in Hounsﬁeld units among offspring groups are
genes involved in de novo lipogenesis, fatty acid (FA) storage and transport, mitochondrial fatty
to the housekeeping gene Ppia of (B)male offspring (n = 11mat-CD/13mat-HFD), (C)mat-CD
the age of 9 months. Mean ± s.e.m., *p b 0.05, **p b 0.01, *** p b 0.001. Nr1h3 = also knownfound to be elevated in steatotic livers [44,45]. We also found the
mRNA levels of the steatosis regulators liver X receptor alpha (Nr1h3,
also known as Lxra) and glucocorticoid receptor (Nr3c1, also known
as Gr) being signiﬁcantly upregulated in 9-month-old mat-HFD versus
mat-CD males (Fig. 3B). The GR target gene hairy and enhancer of splitNr
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female) ormaternal high-fat, high-calorie diet (mat-HFD; n = 8male/6 female) at the age
shown by different letters (p b 0.05); mean ± s.e.m. (B, C, D)mRNA expression of hepatic
acidβ-oxidation, and steatosis regulation by glucocorticoid receptor (GR) signaling relative
offspring (n = 11male/12 female), and (D)mat-HFD offspring (n = 13male/9 female) at
as Lxra; Nr3c1 = also known as Gr.
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repressive effects of GR on Hes1 [46] (Fig. 3B). In contrast to males,
there were no signiﬁcant alterations in gene expression between the
mat-CD and mat-HFD females at that age, except for a difference in he-
patic Pparg1 transcript (age 9 months:mean ± s.e.m.; CD: 1.06 ± 0.11;
HFD: 0.68 ± 0.16; p = 0.017) and, at age 5 months, in acetyl-coenzyme
A carboxylase 1 (Acaca) (mean ± s.e.m.; CD: 1.09 ± 0.15; HFD:
1.72 ± 0.13; p = 0.008).
Next, liver transcripts of males were comparedwith females for sex-
related differences in response to the peri-conceptional dietary expo-
sure. When offspring were exposed to maternal CD in utero, there
were no sex-related differences in liver gene expression (Fig. 3C,
Supplemental Fig. A.2B). However, maternal HFD exposure led to
increased mRNA expression of Srebf1, Fasn, Pparg 1 and 2 in male com-
pared to female livers at age 9 months (Fig. 3D). Pparg 1 and 2 were
signiﬁcantly inﬂuenced by sex and the interaction diet ∗ sex, i.e.mater-
nal diet had an impact on their sex-speciﬁc expression (Table 5).
Expression of the PPARG target genes Cd36 antigen (Cd36), perilipin 2
(Plin2), and fatty acid binding protein 4 (Fabp4), involved in fatty acid
transport and storage, was not signiﬁcantly different in the comparisons
of groups (Fig. 3B, D). Furthermore, transcripts ofβ-oxidation regulators
(peroxisome proliferator activated receptor alpha, Ppara, and Cpt1)
also did not show signiﬁcant alterations, whereas genes required forTable 5
Inﬂuence of the maternal diet, sex, and the interaction of maternal diet ∗ sex on offspring
gene expression levels in the liver and visceral adipose tissue at the age of 9 months.
p-values obtained using ANOVA are shown. p b 0.05was considered signiﬁcant (designated
in boldface type).
Offspring at age 9 months
Genes Maternal diet Sex Maternal diet ∗ sex
Liver tissue Nr1h3 0.0025 0.8542 0.8308
Srebf1 0.0740 0.0506 0.0980
Fasn 0.0082 0.1259 0.1011
Acaca 0.0533 0.7464 0.7498
Pparg1 0.9606 0.0137 0.0205
Pparg2 0.0362 0.0051 0.0084
Cd36 0.4150 0.1749 0.2209
Fabp4 0.4631 0.3302 0.3037
Plin2 0.0235 0.9699 0.9831
Ppara 0.9240 0.9608 0.8520
Cpt1 0.5860 0.7605 0.9821
Nr3c1 0.0081 0.4901 0.4402
Hes1 0.1906 0.3315 0.1752
Visceral adipose tissue Pparg2 0.6694 0.6460 0.4903
Fasn 0.5665 0.0144 0.0121
Acaca 0.5900 0.1979 0.1426
Scd2 0.1404 0.3466 0.6589
Me1 0.9944 0.0355 0.0109
Acly 0.0367 0.3609 0.4089
Bax 0.8084 0.0722 0.0372
Bcl2 0.6038 0.2920 0.1990
Mest 0.2245 0.0837 0.0977
Sfrp5 0.1925 0.2237 0.4403
Bscl2 0.9581 0.0342 0.0208
Pnpla2 0.0868 0.0017 0.0010
Cidea 0.8331 0.9598 0.3733
Lep 0.5093 0.0708 0.4108
Acaca, acetyl-CoenzymeA carboxylase 1;Acly, ATP citrate lyase;Bax, Bcl2-associatedX pro-
tein; Bcl2, B cell leukemia/lymphoma 2; Bscl2, Berardinelli–Seip congenital lipodystrophy 2
(also known as seipin); Cd36, Cd36 antigen; Cidea, cell death-inducing DNA fragmentation
factor, alpha subunit-like effector A; Cpt1, carnitine palmitoyltransferase 1; Fabp4, fatty
acid binding protein 4; Fasn, fatty acid synthase; Hes1, hairy and enhancer of split 1;
Lep, leptin;Me1, malic enzyme 1;Mest, mesoderm-speciﬁc transcript/imprinted paternally
expressed gene 1 (also known as Peg1); Nr3c1, nuclear receptor subfamily 3, group C,
member 1 (also known as Gr, glucocorticoid receptor); Nr1h3, nuclear receptor subfamily
1, groupH,member 3 (also knownas Lxra, liver X receptor alpha); Plin2, perilipin 2; Pnpla2,
patatin-like phospholipase domain-containing protein 2 (also known as Atgl, adipose tri-
glyceride lipase); Ppara, peroxisome proliferator activated receptor alpha; Pparg, peroxi-
some proliferator activated receptor gamma; Scd2, stearoyl-Coenzyme A desaturase 2;
Sfrp5, secreted frizzled-related sequence protein 5; Srebf1, sterol regulatory element bind-
ing transcription factor 1.de novo lipogenesis were upregulated in male offspring exposed to ma-
ternal HFD (Fig. 3B, D). These ﬁndings point to an imbalance between
de novo lipogenesis and β-oxidation which could contribute to the
excess fat accumulation in male liver. Similar sex-speciﬁc relation-
ships were obtained for offspring at an earlier adult age of 5 months
(Supplemental Fig. A.2C).
3.5. Sex-speciﬁc effects on adipose tissue expansion in adult offspring
As compared to mat-CD males, there was a considerably increased
percentage of body fat (Fig. 2E, F, p = 0.002) and visceral fat mass
in adult mat-CD females through life (Table 3, p b 0.001: ages 5 and
9 months), which consisted of adipocytes of larger size than in males
(Fig. 4A). Similar results were obtained for subcutaneous fat mass
(Table 3, p b 0.01: age 5 months, p b 0.001: age 9 months) and adipo-
cyte size (Supplemental Fig. A.3). These ﬁndings represent a constitutive
sex-speciﬁc difference being evident in the absence of anyHFD exposure.
Upon maternal HFD exposure, the mean adipocyte size in visceral
and subcutaneous adipose tissue of adult mat-HFD female offspring was
signiﬁcantly decreased compared tomat-CD females, even to lower levels
than that of male adipocytes (Fig. 4A, Supplemental Fig. A.3A). In males,
there was no such effect of maternal HFD on adipocytes, neither on
mean size nor on fat cell size distribution (Fig. 4A, B, Supplemental
Fig. A.3A, B), whereas the adipocyte size distribution of the mat-HFD
females showed a leftward shift conﬁrming a smaller cell size in this
group (Fig. 4C, Supplemental Fig. A.3C).
Less stored lipids, more apoptosis, or the emergence of smaller
brown adipocytes [47] might explain these ﬁndings in adult mat-HFD
females. We therefore measured transcripts indicative of induced cell
death, brown adipose tissue, adipose mass, and lipid droplet size regu-
lation in visceral fat pads and found a signiﬁcantly upregulated expres-
sion of genes relevant to lipid biosynthetic capacity by generating
NADPH (malic enzyme 1, Me1) and acetyl-CoA (ATP citrate lyase,
Acly) in mat-HFD females compared to their controls (Fig. 4D).
Next, we compared both mat-HFD offspring sexes and analyzed
the results relative to the respective mat-CD controls (Fig. 4D, Supple-
mental Fig. A.4). Striking sex-speciﬁc expression differences between
male and female mat-HFD offspring at age 9 months were identiﬁed
for two key genes involved in lipid droplet size regulation: patatin-
like phospholipase domain-containing protein 2 (Pnpla2, also known
as Atgl), the rate-limiting enzyme of adipose tissue lipolysis, and
Berardinelli–Seip congenital lipodystrophy 2 (Bscl2, also known as
seipin), a regulator of lipid droplet formation [48] (Fig. 4D, Supple-
mental Fig. A.4). Higher mRNA expression levels in mat-HFD females
than males were also measured for Bcl2-associated X protein (Bax),
which codes for a protein involved in apoptotic signaling. Further-
more, analysis of adipocyte transcripts relevant to de novo lipogenesis
revealed signiﬁcant increases in Fasn, Acaca, and Me1 expression in
mat-HFD females compared to mat-HFD males. Remarkably, none of
them was differentially expressed between sexes in mat-CD offspring
(Supplemental Fig. A.4A). ANOVA revealed that among those genes,
expression of Fasn, Me1, Bscl2, and Pnpla2 was signiﬁcantly affected
by both sex and the interaction diet ∗ sex, indicating an additional
inﬂuence of the maternal HFD (Table 5). For Bax, a sex-speciﬁc ex-
pression pattern was only evident through the effects of the interac-
tion diet ∗ sex.
The sex-speciﬁcity of this gene expressionpatternwas evenmore pro-
nounced in mat-HFD offspring at an earlier adult age of 5 months, and
several additional genes were shown to be expressed in a sex-speciﬁc
manner (Supplemental Fig. A.5): stearoyl-Coenzyme A desaturase 2
(Scd2), Acly, leptin (Lep), cell death-inducing DNA fragmentation factor,
alpha subunit-like effector A (Cidea), and the mesoderm-speciﬁc
transcript/imprinted paternally expressed gene 1 (Mest, also known as
Peg1). Among the analyzed genes, only Acly showed a differential
expression between mat-HFD and mat-CD females, which persisted
over time (Supplemental Fig. A.5; Fig. 4D).
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Our data provide evidence that obesogenic stress during the earliest
developmental phases can be sufﬁcient to induce a sex-speciﬁcity in
health outcomes of offspring mice. We found the adverse inﬂuence on
offspring outcome to be organ-speciﬁc, with manifestations at different
times during life. In adulthood of male offspring, overweight, insulin re-
sistance, hyperleptinemia, hyperuricemia, and hepatic steatosis were
observed; all these features were not noted in female offspring. Instead,
those showed impaired fasting glucose suggesting a prediabetic condi-
tion and a reduction in fat mass with adipocytes of smaller size than
in males. Females did not show any visceral fat as early as at 3 weeks
of life, corroborating the hypothesis that this phenotype may be due
to an early “primary” insult. These phenotypes were accompanied by
an underlying HFD-induced sex-speciﬁc regulation of genes involved
in processes determining fatty liver disease, lipid droplet size, and fat
mass expansion.
The exposure to the fetus was deﬁned as an adverse maternal diet
consisting of a higher saturated fat content, sugar-to-starch ratio,
and total energy content than the control diet, which was associated
with only a slightly lowered maternal food and protein consumption,
whereas diet digestibility was kept similarly high. Based on emerging
evidence on programming effects through peri-conceptional and early
gestational nutritional inﬂuences [2,3,49,50], we limited HFD exposure
to this developmental period by fostering all pups to lean dams.
Thereby, inﬂuences of the lactation phase, a period of developmental
plasticity critical to programming of adiposity, energy balance, and
hypothalamic development [6,7] were excluded. Furthermore, any
subsequent postnatal obesogenic challenges were avoided during the
offspring's lifetime. We are aware, however, that suckling of pups
from obese dams on lean fosters and subsequent feeding with control
diet may cause a disadvantageous mismatch between the pre- and
postnatal environment that might inﬂuence offspring outcome via epi-
genetic mechanisms [51]. The process of fostering itself has recently
been reported to lead to sex-speciﬁc cardiovascular andmetabolic alter-
ations and increased white adipose tissue accumulation speciﬁcally in
males [52]. Thus, as we carried out fostering of all offspring of both the
HFD-fed andCD-fed experimental groupof dams,we cannot completely
exclude that an interaction between the prenatal maternal HFD and the
“fostered” phenotype might have contributed to adult adiposity and
metabolic phenotypes observed in our study.
NMRI outbred dams were chosen because we aimed at generating
a model of mild diet-induced maternal adiposity that has less severe
metabolic consequences than standard inbred strains to HFD [28] and
thus shows closer correspondence to the considerable share of over-
weight and obese women without metabolic complications during
pregnancy [53]. Although glucose tolerance of the HFD-fed dams was
impaired in end-term pregnancy, fasting serum glucose and insulin
levels were similar to controls, and there was neither a difference in
the insulin resistance index HOMA-IR nor in adipocytokine levels be-
tween the groups. HFD-fed dams had elevated serum NEFA levels and
reactive oxygen species (H2O2) but a normal serum lipid proﬁle and
no signs of low-grade inﬂammation. They showed a microvesicular
hepatic fat deposition, which only tended to be higher than in controls,
in the absence of any signs of liver injury and inﬂammation. Pregnancy
phenotypes of both NMRI and C57BL/6J dams showed similarities as
to normoglycemia and unaffected lipid levels [25]. In contrast to
the NMRI phenotype, however, diet-induced obese C57BL/6J mice
developed hyperinsulinemia and hyperleptinemia in late pregnancy.
Despite the only few changes in the maternal metabolism of obese
NMRI dams, those could be potentially relevant as mechanistic
factors for adverse offspring outcome. Increased systemic NEFA
levels, presumably arising from adipose tissue lipolysis, are
transported through the placenta and might have an impact on
fetal lipid exposure and regulation of gene expression [54]. Similarly,
increased reactive oxygen species produced in the large adiposetissue mass of dams has been implicated in the development of off-
spring adiposity, possibly by enhancing adipogenesis [55].
Consistent with observations in humans [56], both male and female
offspring of obese dams were found heavier at birth than offspring
of lean dams. Increased expression of placental nutrient transporters
and increased nutrient availability, as observed in HFD-fed pregnant
C57BL/6 mice [24], might contribute to the higher placenta and fetal
weights in the offspring of HFD-fed NMRI dams. However, growth tra-
jectories of the differently exposed offspring groups became aligned
within a few days of life, excluding alterations in early postnatal growth
velocity as a critical determinant of adult disease risk [57]. Notably, this
also shows the absence of an immediate short-term effect of fostering
on each of the offspring sexes.
Male mat-HFD offspring mice showed an adult onset of adiposity,
whereas adult female mat-HFD offspring displayed a reduced fat mass
already as early as at 3 weeks after birth and onwards. These ﬁndings
were attributed to an increased deposition of subcutaneous fat in male
and a diminished visceral fat depot in female offspring. Imbalances
in energy regulation at the early onset of obesity are generally small
requiring the precise measurement of energy ﬂux in early life time
[42]. We could not identify imbalances in energy regulation by moni-
toring energy expenditure and energy intake resulting in increased or
decreased body fat. In late adult age, male offspring also showed insulin
resistance, hyperinsulinemia, hyperleptinemia, and hyperuricemia.
Comparable effects on male offspring have previously been shown only
upon more pronounced obesogenic alterations of the peri-conceptional
environment in rat models of maternal obesity [9,10] and were most
evident when male offspring were additionally overfed postnatally.
Distinct from our offspring outcomes, C57BL/6J mouse studies that
prolonged the obesogenic exposure until the end of the lactation
phase showed a broader spectrum of offspring features, including adi-
posity, hyperlipidemia, hyperinsulinemia, hyperleptinemia, and glucose
intolerance manifesting at an early age of 3 months [25,58]. Studies
in Wistar rats applying the same obesogenic exposure followed by
weaning onto standard chow and investigating both offspring sexes
separately revealed insulin resistance only in males of the same early
age [16]. Comparison of offspring outcomes of rodents being lard-fed
during pregnancy and lactation indicated that more adverse effects
were conﬁned to females than males, such as the development of a
raised blood pressure in Sprague–Dawley rats [15] and adiposity in
C57BL/6J mice [17]. Similar early and detrimental metabolic effects
on female C57BL/6J mouse offspring were seen when offspring were
exposed to a sucrose-rich maternal diet until weaning [59].
Notably, NMRI mat-HFD males did not show fasting hyperglycemia
suggesting that the hyperinsulinemia observed was still sufﬁcient to
maintain normoglycemia. In contrast, mat-HFD females showed fasting
hyperglycemia at the same late adult age of 9 months, which points to
a more pronounced impairment of pancreatic islet function and to a
prediabetic metabolic status at this advanced age. Thus, subsequent
to a peri-conceptional obesogenic exposure, adult male NMRI mice ap-
pear to have greater compensatory capacities regarding glucose homeo-
stasis than females, also reﬂected by the ANOVA results indicating an
impact of the maternal adipogenic diet on the sex-speciﬁc differences
in insulin and HOMA-IR. This ﬁnding is concordant with a signiﬁcantly
higher insulin secretion observed in human male adult offspring
of obese mothers than in female offspring [23] and, as noted in adult
mouse offspring of obese dams, an impaired beta-cell function only in
females [19].
Furthermore, in male but not in female offspring, hepatic derange-
ment was demonstrated morphologically by CT and accompanied by a
mat-HFD induced upregulation of genes involved in the progression
from steatosis to steatohepatitis and non-alcoholic fatty liver disease
(NAFLD) development. This pattern of sex-linked liver gene regulation
persisted throughout adulthood. Among those sex-speciﬁc genes in-
duced in male offspring were nutrient-sensing mediators including
Pparg (both isoforms) and Srebf1 shown to be increased in human and
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may facilitate triglyceride deposition in the liver, thereby serving an
anti-lipotoxic function as a buffer for toxic lipid species, such as sug-
gested for PPARG2 [60]. Additionally, the imbalanced gene expression
we observed between upregulated de novo lipogenesis and unaltered
fatty acid β-oxidation might have contributed to the steatotic hepatic
changes identiﬁed only in male but not in female offspring. This sex dif-
ference also reﬂects epidemiological data in humans of male gender
being a risk factor for NAFLD [61].
In addition to the differences in fat masses between sexes, we also
observed a sex-speciﬁc constitutive variation in visceral and subcuta-
neous adipocyte size revealing larger cells in mat-CD females than in
mat-CD males. This ﬁnding corroborates prior knowledge on known
sex differences in the development of body composition and adipocyte
size in mice and humans [62,63]. However, in view of the fat mass
expansion we found in mat-HFD males, the contrary reduction in
weight and adipocyte size of subcutaneous and visceral fat depots of
mat-HFD female offspring mice was surprising. Those ﬁndings were
accompanied by hyperleptinemia in mat-HFD males and, despite the
very low fat mass, relatively high leptin levels in mat-HFD females,
which might suggest an increased susceptibility towards leptin secre-
tion subsequent to the peri-conceptional HFD exposure. This female
adipocyte phenotype, already being evident in visceral fat at 3 weeks
of life, is pointing to an early developmental origin and may suggest
a retardation of fat mass expansion in female offspring. Several mech-
anisms and genes contributing to an abnormal adipocyte expandability
have been proposed to induce the metabolic dysregulations associated
with reduced fat depots [64]. Among these genes known to be in-
volved in pathways inﬂuencing adipocyte size, we identiﬁed genes
that showed a general (inherent) sex-speciﬁc regulation, which was
additionally inﬂuenced by the adipogenic exposure, i.e. Bscl2, Pnpla2,
Fasn and Me1.
The signiﬁcant upregulation of Bscl2 inmat-HFD female compared to
male adipocytes is particularly interesting in light of the recent ﬁnding
that overexpression of the Bscl2 gene in mice markedly reduced the
mass of white adipose tissue and the size of adipocytes and lipid drop-
lets [65]. In conjunction with the upregulation of Pnpla2 coding for the
adipose tissue triglyceride lipase PNPLA2, the key enzyme of lipolysis
initiation [66], such differential expression might provide an additional
mechanistic clue to explain the mat-HFD female adipocyte phenotype.
While we found a signiﬁcantly upregulated expression of de novo
lipogenesis-related genes (Fasn, Me1), also in comparison of mat-HFD
and mat-CD females (Acly,Me1), this does not necessarily reﬂect corre-
sponding changes in enzymatic activity or metabolic ﬂux. Upregulated
gene expression might equally be an adaptive response to reduced
de novo lipogenesis activity [67] as our offspring mice did not get any
postnatal HFD challenge. Small adipocytes apparently have high
lipogenic potential during the early stages of differentiation to initiate
the process of lipid accumulation, whereas de novo lipogenesis is subse-
quently downregulated as adipocytes expand [68,69].
A speciﬁc HFD-induced sexual dimorphic regulation was addition-
ally identiﬁed for the pro-apoptotic signaling target BAX, a key regulator
of mitochondrial outer membrane permeabilization and mediator of
sensitivity to necrosis [70]. This suggests that apoptotic signals might
additionally have contributed to the visceral adipose tissue phenotype
of mat-HFD female offspring.
Taken together, these data are consistent with the hypothesis
of an early obesogenic nutritional “hit” and developmental origin of
sex-dependent susceptibilities towards adipose tissue formation. The
placenta might play a crucial role in mediating such effects to the
fetus and offspring. Previous studies report that feeding C57BL/6J mice
a HFD during pregnancy leads to modiﬁed expression of imprinted
genes and local or genome-wide DNA methylation in placenta and
that these effects are sex-speciﬁc [18,71]. One may speculate that the
sex-dimorphic differences we observed in offspring adult outcome
may represent the consequence and transgenerational ﬁxation ofdetrimental dietary exposures on the placenta during the early prenatal
period. Consistent with such a hypothesis is the important ﬁnding of
this study that sex-speciﬁc adverse offspring outcomes occurred even
in the absence of any postnatal HFD challenges.
The peri-conceptional obesogenic exposure in the NMRI dams
resulted in rather mild metabolic complications of maternal adiposity.
In humans, this would correspond to the commonly encountered ges-
tational conditions of overweight or milder forms of obesity. Due to
the lack of evidence on long-term health outcomes, those conditions
have not yet been included in recent clinical guidelines for preventive
action to ameliorate obesity in adults or speciﬁcally in women of
fertile age [72]. Nonetheless, at least in our rodent model, such an
obesogenic environment during the earliest phases of development
was sufﬁcient to induce long-term adverse effects in offspring pheno-
typic outcomes and sex-dimorphic gene expression patterns. This indi-
cates varying developmental vulnerabilities between sexes towards
overnutrition.
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